- Home
- CAPL vs PRME Comparison
CAPL vs PRME Comparison
Compare CAPL & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAPL | PRME |
|---|---|---|
| Founded | 1992 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 794.8M | 666.1M |
| IPO Year | 2012 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CAPL | PRME |
|---|---|---|
| Price | $21.48 | $4.02 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.42 |
| AVG Volume (30 Days) | 25.2K | ★ 3.8M |
| Earning Date | 02-25-2026 | 02-27-2026 |
| Dividend Yield | ★ 9.71% | N/A |
| EPS Growth | ★ 129.06 | N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $3,418,591,000.00 | $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.18 | ★ N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $19.61 | $1.11 |
| 52 Week High | $25.73 | $6.94 |
Technical Indicators
Market Signals| Indicator | CAPL | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 66.82 | 52.62 |
| Support Level | $20.60 | $3.29 |
| Resistance Level | $21.89 | $4.60 |
| Average True Range (ATR) | 0.33 | 0.27 |
| MACD | 0.10 | 0.08 |
| Stochastic Oscillator | 86.39 | 53.82 |
Price Performance
Historical ComparisonAbout CAPL CrossAmerica Partners
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.